De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Simris Group Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Alexis McIntosh

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.3yrs
Gemiddelde ambtstermijn bestuur	3.4yrs

Recente managementupdates

Recent updates

Is Simris Alg (STO:SIMRIS B) A Risky Investment?

Dec 22

CEO

Alexis McIntosh

less than a year

Tenure

Dr. Alexis Roberts McIntosh is Chief Executive Officer of Simris Group AB (PUBL) from March 2024. She holds a Ph D in Medicinal Chemistry.She began her career with GlaxoSmithKline and has since spent the...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christoffer Tell	Chief Financial Officer	3.6yrs	SEK 1.08m	0.17% SEK 100.0k
Alexis McIntosh	Chief Executive Officer	less than a year	geen gegevens	geen gegevens
Heike Enke	Chief Science Officer for Non-ADC Technologies of Simris Biologics	1.3yrs	geen gegevens	geen gegevens

1.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van SIMRIS B wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Lars Magnus Hogstrom	Independent Director	4.8yrs	SEK 70.00k	0.52% SEK 312.5k
Steven Schapera	Independent Chairman	no data	SEK 140.00k	8.74% SEK 5.2m
Jonathan Royce	Director	less than a year	geen gegevens	geen gegevens
Frank Puccio	Independent Director	3.4yrs	SEK 70.00k	1.34% SEK 807.1k

3.4yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SIMRIS B wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).

Simris Group Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Simris Group AB (Publ) Appoints Jonathan Royce as Members of the Board

Insufficient new directors

Simris Group AB (publ) Announces Robert Quandt Declines Re-Election as Member of Board

Simris Group AB (PUBL), Annual General Meeting, Jun 28, 2024

Simris Group AB (PUBL) Announces CEO Changes

Independent Chairman recently bought kr6.4m worth of stock

Recent updates

New major risk - Share price stability

Second quarter 2024 earnings released

Simris Group AB (Publ) Appoints Jonathan Royce as Members of the Board

Insufficient new directors

Simris Group AB (publ) Announces Robert Quandt Declines Re-Election as Member of Board

Simris Group AB (PUBL) to Report Q3, 2024 Results on Nov 13, 2024

Simris Group AB (PUBL), Annual General Meeting, Jun 28, 2024

Simris Group AB (PUBL) Announces CEO Changes

Full year 2023 earnings released: kr0.11 loss per share (vs kr0.17 loss in FY 2022)

Third quarter 2023 earnings released

Simris Group AB (PUBL) announced that it has received SEK 2.9295 million in funding

Independent Chairman recently bought kr6.4m worth of stock

New major risk - Shareholder dilution

Independent Chairman recently bought kr55k worth of stock

Simris Group AB Confirms New Patent Application from Its Adc-Payload Platform

Second quarter 2023 earnings released

Simris Alg AB (publ) to Report Q3, 2023 Results on Nov 08, 2023

Full year 2022 earnings released: kr0.17 loss per share (vs kr0.36 loss in FY 2021)

Full year 2022 earnings released: kr0.14 loss per share (vs kr0.36 loss in FY 2021)

Is Simris Alg (STO:SIMRIS B) A Risky Investment?

Second quarter 2022 earnings released: kr0.039 loss per share (vs kr0.092 loss in 2Q 2021)

Simris Alg AB (publ) (OM:SIMRIS B) entered into a binding Letter Of Intent to acquire 100% of the shares in Cyano Biotech GmbH.

Interim Executive Chairman recently bought kr1.0m worth of stock

First quarter 2022 earnings released: kr0.051 loss per share (vs kr0.087 loss in 1Q 2021)

No independent directors

First quarter 2022 earnings released

Simris Alg AB (Publ) Appoints Julian Read as Chief Executive Officer, Effective on May 16, 2022

Simris Alg AB (publ), Annual General Meeting, May 25, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released

Interim Executive Chairman recently bought kr149k worth of stock

Chief Executive Officer Fredrika Gullfot has left the company

Second quarter 2021 earnings released

Full year 2020 earnings released: kr0.60 loss per share (vs kr2.29 loss in FY 2019)

New 90-day low: kr0.78

New 90-day low: kr0.80

New 90-day low - kr0.96

Earnings released

Simris Alg AB (publ) to Report Q2, 2020 Results on Aug 18, 2020

New 90-day high - kr2.67

Simris Alg AB (publ) has completed a Composite Units Offering in the amount of SEK 29.074529 million.

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd